In a new job - October 24, 2025
Alvotech announces changes in Global Business Development and Commercial Operations team
Anil Okay, Chief Commercial Officer, is stepping down to serve as Chief Executive Officer of Adalvo. Trisha Durant has joined Alvotech as Senior Vice President, Global Business Development and Commercial Operation, ex-North America. Harshika Sarbajna is Senior Vice President Commercial, North America. Agne Pasko is Vice President Head of Business Development. “I want to thank […]
Agreement - October 23, 2025
Medivir enters licensing agreement with Biossil
Medivir has entered into an exclusive licensing agreement, through which Biossil, Inc. will receive global, exclusive development rights for remetinostat, a clinical-stage topical HDAC inhibitor.
Clinical Trials - October 22, 2025
ACORAI presents positive results
The company has announced results from the 1,600-patient CAPTURE-HF study (Machine-Learning Estimation of Pulmonary Capillary Wedge and Right Atrial Pressures With a Non-Invasive Multi-sensor Device).
Biotech Business - October 22, 2025
Abera reports long-term data for its nasal influenza vaccine
The results show that the vaccine generates strong and long-lasting immune responses both at the mucosal surfaces and systemically.
In a new job - October 22, 2025
Novo Nordisk Board Members leave: “Not possible to reach a common understanding”
The Board of Directors have decided to convene an Extraordinary General Meeting to elect new members of the Board of Directors of Novo Nordisk. The Board proposed a renewal focusing on addition of select, new competencies while also maintaining continuity, whereas the Board of the Foundation wanted a more extensive reconfiguration. “Following dialogue with the […]
Science News - October 21, 2025
New BCI implant shown to restore functional central vision
The New England Journal of Medicine (NEJM) has published a peer-reviewed original paper with the results of a clinical trial demonstrating the efficacy of Science Corporation’s PRIMA brain-computer interface (BCI) retinal implant.